Insider Transactions Reported by 23 Insiders of Candel Therapeutics, Inc.

Symbol
CADL on Nasdaq
Location
Needham, MA

Insiders trading volume in the past year

Candel Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Estuardo Aguilar-Cordova 10%+ Owner $52,549,421 21 Feb 2025
Paul B Manning Director $24,691,689 25 Jun 2025
Laura K. Aguilar 10%+ Owner $2,742,246 06 May 2022
Christopher Martell Director $2,614,821 25 Jun 2025
Paul Peter Tak Chief Executive Officer, Director $1,254,203 -$229,624 -15% 26 Jan 2026
JOSEPH C. PAPA Director $482,929 25 Jun 2025
Francesca Barone Chief Scientific Officer $470,778 -$281,673 -37% 26 Jan 2026
Seshu Tyagarajan Chief Technology Officer $424,339 -$275,947 -39% 26 Jan 2026
William Garrett Nichols Chief Medical Officer $366,401 -$407,472 -53% 26 Jan 2026
Charles Schoch Chief Financial Officer $202,635 -$44,169 -18% 26 Jan 2026
Jason Amello Chief Financial Officer $181,808 28 Nov 2023
Udi Meirav Director $43,940 26 Jul 2021
SMITH ALAN E Director $29,293 26 Jul 2021
Gary J. Nabel Director $24,998 25 Jun 2025
Nicoletta Loggia Director $9,998 25 Jun 2025
John Canepa Chief Financial Officer $9,113 28 Feb 2022
Nathan Caffo Chief Business Officer $5,400 29 Jul 2021
Maha Radhakrishnan Director 04 Jun 2025
Diem Nguyen Director 17 Jun 2025
Susan B. Stewart Chief Regulatory Officer 11 Apr 2022
Shaan-Chirag C. Gandhi Director 26 Jul 2021
Renee Gaeta Director 17 Jun 2025
Edward J. Benz JR Director 17 Jun 2025

Recent Insider Transactions by Companies or Individuals for Candel Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.